Metoprolol Succinate
Metoprolol Succinate
19 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 70 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Metoprolol Succinate
Average across 70 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 33 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 25 | SUPPLYING |
| Proficient Rx LP | repackager | 19 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | repackager | 17 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 16 | SUPPLYING |
| Northwind Health Company, LLC | repackager | 12 | SUPPLYING |
| Granules Pharmaceuticals Inc. | unknown | 12 | SUPPLYING |
| NorthStar Rx LLC | relabeler | 11 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | repackager | 7 | SUPPLYING |
| Cardinal Health 107, LLC | repackager | 6 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 6 | SUPPLYING |
| A-S Medication Solutions | repackager | 6 | SUPPLYING |
| American Health Packaging | repackager | 6 | SUPPLYING |
| Redpharm Drug | repackager | 5 | SUPPLYING |
| Quallent Pharmaceuticals Health LLC | unknown | 4 | SUPPLYING |
+ 5 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Metoprolol Succinate Tablet, Extended Release — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Cardiovascular.
Metoprolol Succinate Tablet, Extended Release — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Cardiovascular.
Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide
Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide
Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide
Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide
Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term. — Recalling firm: Granules Pharmaceuticals Inc. — Nationwide in the USA.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. — Recalling firm: CARDINAL HEALTHCARE — Nationwide USA
Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets. — Recalling firm: Dr. Reddy's Laboratories, Inc. — Nationwide
Failed Dissolution Specifications: Failure of dissolution test observed at the 18 month time point. — Recalling firm: Dr. Reddy's Laboratories, Inc. — Nationwide
Failed Dissolution Specification; 12-Month stability interval. — Recalling firm: Dr. Reddy's Laboratories, Inc. — LA, MI, MO, MS & OH